Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

HER2 Positive Gastric Cancer × pyrotinib × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 2 Stomach Neoplasms 1 HER2 Positive Gastric Cancer 1 HER-2 Positive Colorectal Cancer 1 Esophageal Squamous Cell Carcinoma 1 Digestive System Neoplasms 1

Interventions

pyrotinib 1 pembrolizumab 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02378389 2015-03-04

Study Evaluating Pyrotinib/Pyrotinib in Combination With Docetaxel in Patients With HER2+ Advanced Gastric Cancer

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Unknown

Gastrointestinal

HER2 Positive Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡